Xeris Biopharma Holdings Inc (XERS)
2.925
-0.04
(-1.18%)
USD |
NASDAQ |
Sep 20, 16:00
2.92
0.00 (0.00%)
After-Hours: 18:54
Xeris Biopharma Holdings Shareholders Equity (Quarterly): -19.29M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -19.29M |
| March 31, 2024 | -9.178M |
| December 31, 2023 | -6.782M |
| September 30, 2023 | 3.865M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 30.05M |
| December 31, 2022 | 45.19M |
| September 30, 2022 | 55.04M |
| June 30, 2022 | 73.94M |
| March 31, 2022 | 96.46M |
| December 31, 2021 | 95.23M |
| September 30, 2021 | -2.461M |
| June 30, 2021 | 19.89M |
| March 31, 2021 | 44.39M |
| Date | Value |
|---|---|
| December 31, 2020 | 33.76M |
| September 30, 2020 | 14.34M |
| June 30, 2020 | 24.38M |
| March 31, 2020 | 27.07M |
| December 31, 2019 | 14.44M |
| September 30, 2019 | 43.66M |
| June 30, 2019 | 74.79M |
| March 31, 2019 | 107.10M |
| December 31, 2018 | 75.41M |
| September 30, 2018 | 95.12M |
| June 30, 2018 | 109.34M |
| March 31, 2018 | 32.85M |
| December 31, 2017 | -57.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-19.29M
Minimum
Jun 2024
96.46M
Maximum
Mar 2022
29.88M
Average
25.72M
Median
Shareholders Equity (Quarterly) Benchmarks
| Zoetis Inc | 4.966B |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 331.73M |
| Total Liabilities (Quarterly) | 351.02M |
| Debt to Equity Ratio | -11.95 |
| Current Ratio | 2.256 |
| Net Debt Paydown Yield | -2.56% |